Mar 24, 2026 10:19AM Jefferies on CytomX Therapeutics (CTMX): 'we see good entry point at current value' amid Vareseta-M derisking

Mar 23, 2026 09:29AM CytomX Therapeutics (CTMX) PT Raised to $12 at Piper Sandler

Mar 18, 2026 10:16AM CytomX Therapeutics (CTMX) PT Raised to $16 at Jefferies: 'buying opportunity here'

Mar 17, 2026 06:33AM CytomX Therapeutics (CTMX) PT Raised to $15 at Guggenheim

Mar 16, 2026 04:04PM CytomX Therapeutics (CTMX) files mixed shelf

Mar 16, 2026 12:02PM CytomX Therapeutics (CTMX) PT Raised to $17 at H.C. Wainwright

Mar 16, 2026 11:57AM JPMorgan Upgrades CytomX Therapeutics (CTMX) to Overweight

Mar 16, 2026 09:30AM CytomX Therapeutics (CTMX) PT Raised to $12 at Oppenheimer

Mar 16, 2026 07:01AM CytomX reports positive phase 1 data for colorectal cancer treatment

Feb 4, 2026 09:51AM CytomX Therapeutics (CTMX) PT Raised to $10 at Cantor Fitzgerald

Jan 20, 2026 07:43AM CytomX Therapeutics (CTMX) PT Raised to $10 at Piper Sandler

Dec 21, 2025 04:00AM Biotechnology: Here are Piper Sandler's Top Picks and Focus Names for 2026

Dec 5, 2025 06:46AM H.C. Wainwright Reiterates Buy Rating on CytomX Therapeutics (CTMX)

Nov 20, 2025 07:08AM CytomX (CTMX) Can Unlock a Much Higher Valuation - Cantor Fitzgerald

Nov 10, 2025 07:25AM CytomX Therapeutics (CTMX) PT Raised at Piper Sandler Amid 'Encouraging CX-801 Data'

Nov 6, 2025 04:32PM CytomX Therapeutics (CTMX) Misses Q3 EPS by 4c

Oct 20, 2025 04:05PM CytomX Therapeutics names Rachael Lester chief business officer

Sep 22, 2025 07:41AM Cantor Fitzgerald Starts CytomX Therapeutics (CTMX) at Overweight

Sep 17, 2025 04:37AM Barclays Starts CytomX Therapeutics (CTMX) at Overweight

Aug 7, 2025 04:13PM CytomX Therapeutics (CTMX) Tops Q2 EPS by 6c, Misses on Revenue

Jul 31, 2025 06:02AM Oppenheimer Starts CytomX Therapeutics (CTMX) at Outperform

May 19, 2025 08:02AM CytomX Therapeutics (CTMX) Announces First Patient Dosed in Combination Arm of Phase 1 Study of CX-801 plus KEYTRUDA

May 15, 2025 06:41AM H.C. Wainwright Upgrades CytomX Therapeutics (CTMX) to Buy, 'EpCAM ADC Data Are Highly Impressive'

May 12, 2025 06:52AM CytomX Therapeutics (CTMX) Prices 76.92M Share Offering at $1.30/sh

May 12, 2025 06:49AM CytomX Therapeutics (CTMX) Reports Positive Interim Data From Phase 1 Dose Escalation Study of CX-2051

May 12, 2025 06:16AM CytomX Therapeutics (CTMX) Tops Q1 EPS by 21c

Apr 28, 2025 04:00PM CytomX Therapeutics (CTMX) Presents Preclinical Data for mRNA Encoded Masked IL-12 Molecule in Collaboration with Moderna

Apr 14, 2025 06:37AM Piper Sandler Assumes CytomX Therapeutics (CTMX) at Overweight

Jan 7, 2025 06:53AM H.C. Wainwright Reiterates Neutral Rating on CytomX Therapeutics (CTMX)

Jan 6, 2025 04:05PM CytomX Therapeutics (CTMX) Announces 2025 Strategic Pipeline Priorities and Provides Corporate Update

Nov 8, 2024 09:13AM CytomX Therapeutics (CTMX) PT Raised to $3.68 at BMO Capital

Nov 8, 2024 08:45AM CytomX Therapeutics (CTMX) PT Lowered to $3.25 at Piper Sandler

Nov 7, 2024 04:37PM CytomX Therapeutics (CTMX) Tops Q3 EPS by 24c

Sep 13, 2024 06:47AM H.C. Wainwright Reiterates Neutral Rating on CytomX Therapeutics (CTMX)

Aug 9, 2024 04:10PM CytomX Therapeutics (CTMX) Files $250M Mixed Shelf

Aug 9, 2024 07:58AM CytomX Therapeutics (CTMX) PT Lowered to $3.56 at BMO Capital

Aug 8, 2024 04:23PM CytomX Therapeutics (CTMX) Tops Q2 EPS by 2c

Jun 27, 2024 06:38AM H.C. Wainwright Reiterates Neutral Rating on CytomX Therapeutics (CTMX)

Jun 17, 2024 04:15PM CytomX Therapeutics (CTMX) Appoints Chris Ogden as CFO